Literature DB >> 19870770

IMMUNITY OF MICE FOLLOWING SUBCUTANEOUS VACCINATION WITH ST. LOUIS ENCEPHALITIS VIRUS.

L T Webster1.   

Abstract

1. Susceptible mice injected subcutaneously or intraperitoneally with 15,000 intracerebral lethal doses of St. Louis encephalitis virus develop an immunity in 4 to 7 days to 1,000 to 1,000,000 lethal doses given either intracerebrally or intranasally. 2. This immunity persists 4 to 6 weeks, then decreases gradually and disappears after 8 to 12 weeks. 3. More than 1,000 intracerebral doses of virus given as a vaccine do not materially increase the amount or duration of the immunity; less than 1,000 doses give little or no immunity. 4. Test virus injected intracerebrally into immunized mice induces few lesions and is rapidly destroyed; instilled intranasally, it rarely reaches the olfactory lobes or brain. 5. While immunity is maximum, circulating neutralizing antibodies are not detectable. Moreover, the immunity is not affected by endothelial cell blockade or by splenectomy. 6. A few moments after the immunizing virus is given, it can be recovered from the blood in relatively high concentration. After 24 hours, the blood no longer contains demonstrable virus nor do any organs thus far tested except the spleen. The brain and cord remain entirely normal. The spleen, however, becomes enlarged and harbors virus for as long as 30 days.

Entities:  

Year:  1938        PMID: 19870770      PMCID: PMC2133662          DOI: 10.1084/jem.68.1.111

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  Immunity to Virus Diseases.

Authors:  E W Goodpasture
Journal:  Am J Public Health Nations Health       Date:  1936-12

2.  Diagnostic and Immunological Tests of Rabies in Mice.

Authors:  L T Webster
Journal:  Am J Public Health Nations Health       Date:  1936-12

3.  On the Problem of Immunization Against Poliomyelitis.

Authors:  E W Schultz; L P Gebhardt
Journal:  Cal West Med       Date:  1935-08

4.  EXPERIMENTS ON ACTIVE IMMUNIZATION AGAINST EXPERIMENTAL POLIOMYELITIS.

Authors:  P K Olitsky; H R Cox
Journal:  J Exp Med       Date:  1936-01-01       Impact factor: 14.307

5.  HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS.

Authors:  A B Sabin; P K Olitsky
Journal:  J Exp Med       Date:  1936-10-31       Impact factor: 14.307

6.  THE LIMITED NEUROTROPIC CHARACTER OF THE ENCEPHALITIS VIRUS (ST. LOUIS TYPE) IN SUSCEPTIBLE MICE.

Authors:  L T Webster; A D Clow
Journal:  J Exp Med       Date:  1936-02-29       Impact factor: 14.307

7.  EXPERIMENTAL ENCEPHALITIS (ST. LOUIS TYPE) IN MICE WITH HIGH INBORN RESISTANCE : A CHRONIC SUBCLINICAL INFECTION.

Authors:  L T Webster; A D Clow
Journal:  J Exp Med       Date:  1936-05-31       Impact factor: 14.307

  7 in total
  4 in total

1.  BLOOD-SUCKING VECTORS OF ENCEPHALITIS: EXPERIMENTAL TRANSMISSION OF ST. LOUIS ENCEPHALITIS (HUBBARD STRAIN) TO WHITE SWISS MICE BY THE AMERICAN DOG TICK, DERMACENTOR VARIABILIS SAY.

Authors:  R J Blattner; F M Heys
Journal:  J Exp Med       Date:  1944-04-01       Impact factor: 14.307

2.  INTRAPERITONEAL AND INTRACEREBRAL ROUTES IN SERUM PROTECTION TESTS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : III. COMPARISON OF ANTIVIRAL SERUM CONSTITUENTS FROM GUINEA PIGS IMMUNIZED WITH ACTIVE OR FORMOLIZED INACTIVE VIRUS.

Authors:  P K Olitsky; C G Harford
Journal:  J Exp Med       Date:  1938-10-31       Impact factor: 14.307

3.  EFFECT OF PREGNANCY UPON THE IMMUNITY OF MICE VACCINATED AGAINST ST. LOUIS ENCEPHALITIS VIRUS.

Authors:  H L Hodes
Journal:  J Exp Med       Date:  1939-03-31       Impact factor: 14.307

4.  INFLUENCE OF AGE ON SUSCEPTIBILITY OF MICE TO ST. LOUIS ENCEPHALITIS VIRUS AND ON THE DISTRIBUTION OF LESIONS.

Authors:  J L O'Leary; M G Smith; H R Reames
Journal:  J Exp Med       Date:  1942-01-31       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.